Pharma manufacturers that don’t invest in continuous manufacturing will be forced out of market

Home  /  Blog-news  /  Pharma manufacturers that don’t invest in continuous manufacturing will be forced out of market

On March 28, 2019, Posted by

CPhI Annual Report warns pharma manufacturers that don’t invest in continuous manufacturing will be forced out of market.

Within the report, experts consulted predict exponential growth of continuous manufacturing driven by competitive and financial pressures, better equipment and a larger pool of trained scientists.  Also is predicted that all generic manufacturers and CMOs will need to convert to continuous manufacturing facilities in the next 10-years.

You can read the article in detail here.